देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
CITALOPRAM (CITALOPRAM HYDROBROMIDE)
MINT PHARMACEUTICALS INC
N06AB04
CITALOPRAM
10MG
TABLET
CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10MG
ORAL
100
Prescription
SELECTIVE-SEROTONIN REUPTAKE INHIBITORS
Active ingredient group (AIG) number: 0136243003; AHFS:
CANCELLED POST MARKET
2018-08-01
1 PRODUCT MONOGRAPH PR MINT-CITALOPRAM CITALOPRAM TABLETS, USP 10 MG, 20 MG AND 40 MG CITALOPRAM (AS CITALOPRAM HYDROBROMIDE) ANTIDEPRESSANT MINT PHARMACEUTICALS INC., DATE OF REVISION: 1093 MEYERSIDE DRIVE, UNIT 1, MAY 29, 2014 MISSISSAUGA, ONTARIO L5T 1J6 CONTROL#: 173999 2 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ……………... 3 SUMMARY PRODUCT INFORMATION……………………………….. 3 INDICATIONS AND CLINICAL USE…………………………………… 3 CONTRAINDICATIONS………………………………………………….. 3 WARNINGS AND PRECAUTIONS …………………………………….. 4 ADVERSE REACTIONS ………………………………………………… 11 DRUG INTERACTIONS………………………………………………….. 19 DOSAGE AND ADMINISTRATION……………………………………. 26 OVERDOSAGE…………………………………………………………… 28 ACTION AND CLINICAL PHARMACOLOGY………………………… 29 STORAGE AND STABILITY ……………………………………………. 30 DOSAGE FORMS, COMPOSITION AND PACKAGING………………. 30 PART II: SCIENTIFIC INFORMATION……………………………… 32 PHARMACEUTICAL INFORMATION…………………………………. 32 CLINICAL TRIALS………………………………………………………. 33 DETAILED PHARMACOLOGY…………………………………………. 35 TOXICOLOGY……………………………………………………………. 38 REFERENCES…………………………………………………………….. 42 PART III: CONSUMER INFORMATION …………………………….. 46 3 Pr MINT-CITALOPRAM Citalopram tablets, USP 10 mg, 20, and 40 mg citalopram (as citalopram hydrobromide) PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION INDICATIONS AND CLINICAL USE Adults MINT-CITALOPRAM (Citalopram hydrobromide) is indicated for the symptomatic relief of depressive illness. The relapse rate was signifi पूरा दस्तावेज़ पढ़ें